New distribution center opens in Texas
Woodfield expands third-party logistics (3PL) services from its Florida base
Woodfield Distribution (WDSrx), a growing 3PL for life sciences based in Boca Raton, FL, is expanding to other states. The company has opened a 48,600-sq.ft. facility in Sugar Land, TX that is equipped to handle warehousing and distribution, cold-chain capability, reverse logistics and regulatory-compliant disposition. The total investment is $1.5 million, and is occurring at the same time as a doubling of controlled-substances (Sched. II-V) warehousing at the Boca Raton center. The Sugar Land facility is also in the vicinity of an affiliated Woodfield company, Woodfield Pharmaceutical LLC, a contract manufacturing organization.
“We are increasing our regional presence in response to client demand. Our Sugar Land Center provides needed additional capacity and features the same advanced technologies and efficiencies at our state-of-the-art location in Florida,” said Lawrence Hotz, WDSrx marketing manager, in a statement.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
